Despite a mandate to help patients make better-informed health care decisions, a ten-year research program established under the Affordable Care Act has funded a relatively small number of studies that examine primary care, the setting where the...
14-Apr-2019 5:05 PM EDT Add to Favorites
Georgetown University Medical Center (GUMC) announces the appointment of Deus Bazira, DrPH, MPH, MBA, BPharm, an expert in health systems strengthening and a public health practitioner with decades of in-depth field level practical experience in...
15-Apr-2019 11:30 AM EDT Add to Favorites
A consortium of researchers led by Georgetown Lombardi Comprehensive Cancer Center investigators have completed the largest analysis of a new gene fusion they believe is responsible for development of a wide spectrum of cancer types.
12-Apr-2019 2:00 PM EDT Add to Favorites
As many as a billion people could be newly exposed to disease-carrying mosquitoes by the end of the century because of global warming, says a new study that examines temperature changes on a monthly basis across the world.
25-Mar-2019 5:00 AM EDT Add to Favorites
Georgetown Researchers Launch “Nari Paila,” Mobile Games to Share Information on Fertility Awareness, Family Planning in Nepal
Georgetown researchers have launched a series of mobile games in Nepal to reach young people with information about fertility awareness and family planning.
24-Mar-2019 3:00 PM EDT Add to Favorites
@LombardiCancer-Led Study Leads to First FDA-Approved Drug in Decades to Improve Survival in Small Cell Lung Cancer
The U.S. Food and Drug Administration’s approval today of atezolizumab (Tecentriq®, Genentech) in combination with chemotherapy (carboplatin and etoposide) for the initial treatment of extensive-stage small cell lung cancer (SCLC) marks the end...
18-Mar-2019 8:05 PM EDT Add to Favorites
Results of a first-of-its-kind prospective study with a family planning app find it to be as effective as other modern methods for avoiding an unplanned pregnancy, according to Georgetown researchers.
14-Mar-2019 3:00 AM EDT Add to Favorites
The first arm of a phase II clinical trial by a research team at Georgetown University Medical Center testing the use of nilotinib in patients with Parkinson’s disease demonstrates precisely how the agent increases levels of dopamine in the brains...
8-Mar-2019 2:00 PM EST Add to Favorites
see all news
12-Apr-2019 2:30 PM EDT
.@GuMedCenter Global Health Security, Law Experts React to WHO Decision to Not Declare the DRC Ebola Outbreak a PHEIC
12-Apr-2019 1:15 PM EDT
Genetic testing of women diagnosed with breast cancer could be “impactful.” @LombardiCancer medical oncologist reacts to new guidelines issued by breast surgeons’ organization.
14-Feb-2019 12:10 PM EST
14-Dec-2018 1:05 PM EST
26-Nov-2018 10:05 AM EST
Georgetown #GlobalHealth Experts in Infectious Disease Available to Comment on @WHO Emergency Committee Meeting
16-Oct-2018 4:05 AM EDT
1-Oct-2018 10:05 AM EDT
30-Aug-2018 12:45 PM EDTsee all experts